BackgroundCheck.run
Search For

Hui Dong Li, 8913120 Pomerado Rd UNIT 125C, Poway, CA 92064

Known as:
Dong Huidong Li Huidong Dong Lihui Huidong D Li Dong Li Huidong Dong Lihui Li Huidong Dongli Hui

Hui Li Phones & Addresses

Poway, CA   

Houston, TX   

San Diego, CA   

San Antonio, TX   

Get Report
Control this profile

Mentions for Hui Dong Li

Hui Li resumes & CV records

Resumes

Hui Li Photo 46

Hui Li - St. Louis, MO

Work:
PSA Oct 2012 to Dec 2012
Consultant Intern INGERSOLL RAND (CHINA) INVESTMENT CO., LTD Jun 2012 to Sep 2012
Accounting Intern KPMG (SGP) Jan 2012 to Feb 2012
Audit Intern PINGAN BANK - Shenzhen, CN Aug 2011 to Sep 2011
Law and Compliance Department Intern
Education:
SHANGHAI INTERNATIONAL STUDIES UNIVERSITY Jul 2013
Bachelor of Art in English Language and Literature WASHINGTON UNIVERSITY, OLIN BUSINESS SCHOOL - St. Louis, MO
Master of Accounting
Skills:
Microsoft Office, Oracle Financial System
Hui Li Photo 47

Hui Li

Work:
Post-doctoral Researcher Jan 2010 to 2000 Hui Li 2013 to 2013 Beijing Information Technology Center Embedded Engineering Group Jul 2009 to Jan 2010
project manager to develop a portable Primary developer 2008 to 2008 Beijing E-Dragons Intelligent Network Limited Company Jul 1997 to Jun 2002
a software Hui Li Jul 1994 to May 1997
Education:
College of Computer Science and Technology, Beijing University of Technology 2013
Ph. D. in Computer Application Technology Actuator of this University-Enterprise 2006
doctoral in research College of Computer Science and Technology - Changchun, CN Sep 2001 to Jul 2004
Master of Science in Computer Application Technology College of Computer Science and Technology, Jinlin University - Changchun, CN Sep 1990 to Jul 1994
B.S. in Computer Application Technology ShouGang Research Institute
cooperation
Hui Li Photo 48

Hui Li

Work:
Post-doctoral Researcher Jan 2010 to 2000 Hui Li 2013 to 2013 Beijing Information Technology Center Embedded Engineering Group Jul 2009 to Jan 2010
project manager to develop a portable Primary developer 2008 to 2008 Beijing E-Dragons Intelligent Network Limited Company Jul 1997 to Jun 2002 Changchun Sitong Electronic Communication Company Jul 1994 to May 1997
Education:
College of Computer Science and Technology, Beijing University of Technology Sep 2004 to Jun 2009
Ph. D. in Computer Application Technology Actuator of this University-Enterprise 2006
doctoral in research College of Computer Science and Technology - Changchun, CN Sep 2001 to Jul 2004
Master of Science in Computer Application Technology College of Computer Science and Technology, Jinlin University - Changchun, CN Sep 1990 to Jul 1994
B.S. in Computer Application Technology ShouGang Research Institute
cooperation
Hui Li Photo 49

Hui Li - Prairie Village, KS

Work:
Jackson Hewitt Jan 2012 to 2000
Tax Preparer CTK Biotech - San Diego, CA Jan 2005 to Apr 2005
Shipping Manager
Education:
University of Missouri - Kansas City, KS Apr 2000 to Dec 2011
Bachelor of Science in Accounting Communication University of China Sep 2008
Associated in Journalism Johnson County Community College - Overland Park, KS
Accounting
Hui Li Photo 50

Hui Li - Wilkes-Barre, PA

Work:
Peking Chef Chinese Restaurant Mar 2010 to 2000
Manager Trainee Wilkes University Development Department - Wilkes-Barre, PA Feb 2007 to Apr 2007
Technician Phonathon American Education Center Fuzhou, Fujian Branch Aug 2006 to Dec 2006
Manager Assistant Fuzhou Trust & Investment Co Feb 2004 to Mar 2004
Computer Technician (Intern)
Education:
Wilkes University Graduate School of Business - Wilkes-Barre, PA Jan 2007 to Dec 2009
MBA Fujian Agriculture and Forest University Sep 2004 to Jul 2006
Bachelor's in Computer Science Fuzhou University Sep 2001 to Jul 2004
Associate in majored

Publications & IP owners

Us Patents

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase

US Patent:
7115658, Oct 3, 2006
Filed:
May 9, 2003
Appl. No.:
10/434702
Inventors:
Allen J. Borchardt - San Diego CA, US
Peter Scott Dragovich - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Tanya Michelle Jewell - Encinitas CA, US
Hui Li - Carlsbad CA, US
Maria Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Ru Zhou - Carlsbad CA, US
Thomas Jay Prins - Cardiff CA, US
Melwyn A. Abreo - Jamul CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/351
US Classification:
514460, 514459, 514336, 514365, 514452, 514364, 514378, 514405, 514326, 5142315, 514422, 51425931, 514384, 514397, 5142621, 514456, 5142581, 514382, 51425505, 514369, 514274, 514340, 514363, 514375, 5142541
Abstract:
Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same

US Patent:
7148226, Dec 12, 2006
Filed:
Nov 19, 2003
Appl. No.:
10/718337
Inventors:
Allen Borchardt - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Hui Li - Carlsbad CA, US
Maria Angelica Linton - Linton CA, US
John Howard Tatlock - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/519
US Classification:
5142591, 514397, 514378, 514394, 5142631, 51426323, 514406, 514414, 514383, 544264, 544278, 5482632, 5482642, 5483047, 5483657
Abstract:
The invention relates to compounds of the formula 1.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same

US Patent:
7151105, Dec 19, 2006
Filed:
Aug 15, 2005
Appl. No.:
11/204269
Inventors:
Javier Gonzalez - Oceanside CA, US
Tanya Michelle Jewell - Encinitas CA, US
Hui Li - Carlsbad CA, US
Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Assignee:
Agouron Pharmaceuticals, Inc. - San Diego CA
International Classification:
A61K 31/519
A61K 31/35
A01N 43/90
A01N 43/16
C07D 487/00
US Classification:
51425931, 544263, 514460, 549292
Abstract:
The present invention provides compounds of formula (4), and their pharmaceutically acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme and are also useful for the treatment of HCV infections in HCV-infected mammals. The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formula (4).

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same

US Patent:
7473790, Jan 6, 2009
Filed:
May 8, 2006
Appl. No.:
11/382154
Inventors:
Allen Borchardt - San Diego CA, US
Javier Gonzalez - Oceanside CA, US
Hui Li - Carlsbad CA, US
Maria Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 309/30
C07D 305/00
C07D 309/00
US Classification:
549291, 549263, 549273
Abstract:
The invention relates to compounds of the formula 1.

Inhibitors Of Hepatitis C Virus Rna-Dependent Rna Polymerase, And Compositions And Treatments Using The Same

US Patent:
7622605, Nov 24, 2009
Filed:
Sep 6, 2006
Appl. No.:
11/470540
Inventors:
Javier Gonzalez - Oceanside CA, US
Tanya Michelle Jewell - Encinitas CA, US
Hui Li - Carlsbad CA, US
Angelica Linton - San Diego CA, US
John Howard Tatlock - San Diego CA, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07C 69/34
C07C 69/52
US Classification:
560190
Abstract:
The present invention provides compounds of formula (4), and their pharmaceutically acceptable salts and solvates, which are useful as inhibitors of the Hepatitis C virus (HCV) polymerase enzyme and are also useful for the treatment of HCV infections in HCV-infected mammals. The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates. Furthermore, the present invention provides intermediate compounds and methods useful in the preparation of compounds of formula (4).

3-Amido-Pyrrolo[3,4-C]Pyrazole-5(1H,4H,6H) Carbaldehyde Derivatives

US Patent:
8114871, Feb 14, 2012
Filed:
Apr 10, 2008
Appl. No.:
12/532051
Inventors:
Iriny Botrous - San Diego CA, US
Yufeng Hong - San Diego CA, US
Hui Li - Carlsbad CA, US
Kevin Kun-Chin Liu - San Marcos CA, US
Seiji Nukui - San Diego CA, US
Min Teng - San Diego CA, US
Eileen Valenzuela Tompkins - Escondido CA, US
Chunfeng Yin - San Diego CA, US
Assignee:
Pfizer Inc. - New York NY
Pfizer Products Inc. - Groton CT
International Classification:
A61K 31/535
A61K 31/495
A61K 31/497
A61K 31/4965
C07D 413/14
C07D 237/00
C07D 239/00
C07D 403/14
C07D 241/36
C07D 401/14
US Classification:
5142342, 514249, 51425309, 51425406, 514250, 51425506, 544121, 544230, 544231, 544282, 544295, 544344, 544349, 544363, 544371
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts of Formula (I): wherein X, R, R, R, R, R, R, R, and Rare as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications (including in particular diabetic retinopathy, nephropathy or neuropathy), cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disease pression, viral diseases, inflammatory disorders, or diseases in which the liver is a target organ.

N-Pyrimidin-4-Yl-3-Amino-Pyrrolo[3,4-C]Pyrazole Derivatives As Pkc Kinase Inhibitors

US Patent:
8183255, May 22, 2012
Filed:
Feb 4, 2008
Appl. No.:
12/523965
Inventors:
Hui Li - Carlsbad CA, US
Seiji Nukui - San Diego CA, US
Stephanie Anne Scales - San Diego CA, US
Min Teng - San Diego CA, US
Chunfeng Yin - San Diego CA, US
Assignee:
Pfizer, Inc. - New York NY
International Classification:
A61K 31/505
US Classification:
514275, 544324, 544386, 546245, 5483605, 549356
Abstract:
The present invention relates to compounds and pharmaceutically acceptable salts of Formulas A and B: (A) and (B) wherein A, B, R, R, R, R, R, R, R, R, Rand Rare as defined above. The invention further relates to pharmaceutical compositions comprising the compounds and pharmaceutically acceptable salts and to methods of treating diabetes mellitus and its complications, cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease and dermatological disease pression, virus diseases, inflammatory disorders, or diseases in which the liver is a target organ.

Mobile Navigation System

US Patent:
8200426, Jun 12, 2012
Filed:
Aug 22, 2001
Appl. No.:
09/935463
Inventors:
Qing Kent Pu - San Diego CA, US
Hui Henry Li - San Diego CA, US
Assignee:
Infogation Corporation - San Diego CA
International Classification:
G01C 21/26
US Classification:
701412, 701408
Abstract:
A client navigation system establishes a wireless connection to a navigation server on a computer network. The client requests a route by uploading start and stop specifications. The server calculates an optimal route based on real-time data available on the network. A generic natural language description is used to specify the optimal route downloaded to the client. The natural language description is independent from the local mapping database software on the client and includes a plain text description for each link using pre-defined generic terms. The client interprets the route, interfaces with the local mapping database and reconstructs the optimal route using a mapping reconstruction algorithm. The route is displayed on the client navigation system using whatever mapping database is present. An enhanced user-interface data-entry feature is provided that anticipates data being entered by users to minimize the data-entry process.

Isbn (Books And Publications)

Xian Dai Si Xiang Zheng Zhi Jiao Yu Huan Jing Yan Jiu

Author:
Hui Li
ISBN #:
7218048854

Possible Relatives

Cynthia M Li  David Li  Dawei Li  Dayu W Li  De Li  Dean Li  Da Li  Hui S Jun  Hui T Lee  Hui C Lim 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.